A detailed history of Mendota Financial Group, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mendota Financial Group, LLC holds 650 shares of NBIX stock, worth $81,581. This represents 0.04% of its overall portfolio holdings.

Number of Shares
650
Previous 650 -0.0%
Holding current value
$81,581
Previous $89.5 Million 16.31%
% of portfolio
0.04%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$130.86 - $143.19 $13,086 - $14,319
-100 Reduced 13.33%
650 $89.5 Million
Q1 2024

Apr 25, 2024

SELL
$130.4 - $143.74 $49,160 - $54,189
-377 Reduced 33.45%
750 $103 Million
Q2 2023

Jul 27, 2023

BUY
$89.53 - $104.87 $100,900 - $118,188
1,127 New
1,127 $106 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.